Peer-influenced content. Sources you trust. No registration required. This is HCN.
Women’s Healthcare
A Phase 2 trial of luvesilocin reported rapid reductions in postpartum depression symptoms, with most treated participants reaching remission within seven days. The investigational psychedelic has received FDA Breakthrough Therapy designation, but Phase 3 confirmation remains pending.
Family Nursing July 28th 2026
Journal of Pediatric Nursing (JPN)
Unresolved trauma often resurfaced during the transition of management responsibility, revealing caregiver hypervigilance and adolescent disengagement.
Adolescent Medicine June 10th 2026
OJIN: The Online Journal of Issues in Nursing
Falls are considered a nurse-sensitive incident because fall prevention is impacted by the quantity and quality of nursing care.
Geriatric Nursing May 18th 2026